News related to Remicade (Infliximab) and/or conditions it is approved for
Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.
Remission Comes Sooner With Early Tx for SpA (CME/CE)
Source: MedPage Today Rheumatology [2013.11.20]
(MedPage Today) -- Early treatment of active axial spondyloarthritis (SpA) with naproxen plus infliximab (Remicade) led to high rates of remission, which then were sustained whether patients continued to receive naproxen or not after stopping the infliximab, an international research group reported in two studies.